Cabotegravir-rilpivirine treatment initiation in a nonvirologically suppressed patient
- PMID: 35876710
- DOI: 10.1097/QAD.0000000000003273
Cabotegravir-rilpivirine treatment initiation in a nonvirologically suppressed patient
References
-
- Rizzardini G, Overton ET, Orkin C, Swindells S, Arasteh K, Górgolas Hernández-Mora M, et al. Long-acting injectable cabotegravir + rilpivirine for HIV maintenance therapy: week 48 pooled analysis of phase 3 ATLAS and FLAIR trials . J Acquir Immune Defic Syndr 2020; 85:498–506.
-
- Fernandez C, van Halsema CL. Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential . HIV AIDS (Auckl) 2019; 11:179–192.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical